CSF2 and breast cancer: We have previously demonstrated in a metastatic breast cancer model that KLF4 knockdown reduces granulocyte-macrophage colony-stimulating factor (GM-CSF), which is essential for MDSC development, through regulation of CXCL5, delaying tumor development.